Presentation is loading. Please wait.

Presentation is loading. Please wait.

Adherence and persistence with medication regimens is highly relevant to disease outcomes.

Similar presentations


Presentation on theme: "Adherence and persistence with medication regimens is highly relevant to disease outcomes."— Presentation transcript:

1 Adherence and persistence with medication regimens is highly relevant to disease outcomes

2 Adherence to a medication regimen is generally defined as the extent to which patients take medications as prescribed by their health care provider. 1 1. Osterberg L, Blasche T. N Engl J Med. 2005;353:487-497. 2. Breekveldt-Postma NS et al. Curr Med Res Opin. 2008;24:121-127. Nonpersistence with antihypertensive therapy is associated with an increased risk of myocardial infarction and stroke. 2 Methods that can be used to confirm adherence to a medication regimen include: monitoring of pill count, monitoring of prescription refill rate, and patient use of “smart” pill bottles, but these are all indirect measures.

3 * Defined as the total number of days of therapy for medication dispensed/365 days of study follow-up ACE, angiotensin-converting enzyme; CCB, calcium channel blocker; SPC, single-pill combination Gerbino PP, Shoheiber O. Am J Health System Pharm. 2007;64:1279-1283. SPC (ACE inhibitor + CCB) (n=2839) Free combination (ACE inhibitior + CCB) (n=3367) Medication possession ratio (MPR) * P<0.0001 88% 69% 0%20%40%60%80%100% Prescription of a single-pill combination is associated with improved adherence rates compared with free-combination therapy

4 A new device* approved by the FDA 1 can be included in antihypertensive pills to monitor the adherence to treatment The ingestible sensor is made entirely of ingredients found in food and is activated upon ingestion to transmit a unique number which is captured by an external patch. The ingestible sensor does not require any battery or antenna; it is powered by the contact with stomach fluids. The ingestible sensor can be embedded in a drug product and can be used for directly confirming medication adherence, as part of a networked wellness system. Edible sensor attached directly to a tablet The networked system has already been tested in hypertension and heart failure populations. * The Ingestion Event Marker (IEM), by Proteus Health. 1. FDA approves digestible microchips to be placed in pills. Medscape. August 3, 2012.


Download ppt "Adherence and persistence with medication regimens is highly relevant to disease outcomes."

Similar presentations


Ads by Google